Gabelli Funds LLC Surmodics Inc Transaction History

Gabelli Funds LLC

$13.4 Billion
Q3 2025

A detailed history of Gabelli Funds LLC transactions in Surmodics Inc stock. As of the latest transaction made, Gabelli Funds LLC holds 384,371 shares of SRDX stock, worth $16 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

384,371

Previous 414,838 7.34%

Holding current value

$16 Million

Previous $12.3 Million 6.78%

% of portfolio

0.09%

Previous 0.1%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$29.0 - $38.0 $883,543 - $1.16 Million	-30,467 Reduced 7.34%	384,371 $11.5 Million
Q2 2025 Aug 13, 2025	BUY	$26.76 - $31.1 $517,244 - $601,131	19,329 Added 4.89%	414,838 $12.3 Million
Q1 2025 May 14, 2025	BUY	$26.71 - $39.71 $1.48 Million - $2.21 Million	55,550 Added 16.34%	395,509 $12.1 Million
Q4 2024 Feb 13, 2025	BUY	$37.5 - $40.13 $459,375 - $491,592	12,250 Added 3.74%	339,959 $13.5 Million
Q3 2024 Nov 13, 2024	BUY	$38.47 - $42.24 $2.6 Million - $2.85 Million	67,509 Added 25.95%	327,709 $12.7 Million

Q2 2024 Aug 13, 2024	BUY	$25.39 - $42.1 $5.27 Million - $8.74 Million	207,500 Added 393.74%	260,200 $10.9 Million
Q4 2023 Feb 13, 2024	SELL	$28.47 - $38.49 $8,541 - $11,547	-300 Reduced 0.57%	52,700 $1.92 Million
Q2 2023 Aug 10, 2023	BUY	$17.67 - $31.31 $10,602 - $18,786	600 Added 1.15%	53,000 $1.66 Million
Q1 2023 May 12, 2023	BUY	$17.13 - $38.52 $15,417 - $34,668	900 Added 1.75%	52,400 $1.19 Million
Q1 2022 May 13, 2022	BUY	$40.68 - $49.72 $203,400 - $248,600	5,000 Added 10.75%	51,500 $2.33 Million
Q3 2021 Nov 12, 2021	SELL	$52.8 - $60.32 $501,600 - $573,040	-9,500 Reduced 16.96%	46,500 $2.59 Million
Q2 2021 Aug 13, 2021	SELL	$51.29 - $59.15 $281,069 - $324,142	-5,480 Reduced 8.91%	56,000 $3.04 Million
Q1 2021 May 14, 2021	SELL	$42.18 - $56.07 $275,013 - $365,576	-6,520 Reduced 9.59%	61,480 $3.45 Million
Q4 2020 Feb 05, 2021	SELL	$35.18 - $43.52 $351,800 - $435,200	-10,000 Reduced 12.82%	68,000 $2.96 Million
Q3 2020 Nov 06, 2020	SELL	$37.98 - $48.72 $37,980 - $48,720	-1,000 Reduced 1.27%	78,000 $3.04 Million
Q1 2020 May 14, 2020	SELL	$22.46 - $42.24 $22,460 - $42,240	-1,000 Reduced 1.25%	79,000 $2.63 Million
Q4 2019 Feb 14, 2020	BUY	$39.01 - $47.51 $390,100 - $475,100	10,000 Added 14.29%	80,000 $3.31 Million
Q2 2019 Aug 02, 2019	BUY	$38.23 - $47.43 $57,344 - $71,145	1,500 Added 2.19%	70,000 $3.02 Million
Q1 2019 May 02, 2019	BUY	$41.26 - $58.35 $660,160 - $933,600	16,000 Added 30.48%	68,500 $2.98 Million
Q4 2018 Jan 30, 2019	SELL	$44.93 - $73.38 $314,510 - $513,659	-7,000 Reduced 11.76%	52,500 $2.48 Million
Q3 2018 Nov 02, 2018	SELL	$56.85 - $80.35 $1.35 Million - $1.9 Million	-23,700 Reduced 28.49%	59,500 $4.44 Million
Q2 2018 Aug 10, 2018	SELL	$35.85 - $57.05 $1.21 Million - $1.92 Million	-33,728 Reduced 28.85%	83,200 $4.59 Million
Q1 2018 May 09, 2018	SELL	$27.0 - $38.5 $14,607 - $20,828	-541 Reduced 0.46%	116,928 $4.45 Million
Q4 2017 Feb 02, 2018	SELL	$28.0 - $33.2 $54,992 - $65,204	-1,964 Reduced 1.64%	117,469 $3.29 Million
Q3 2017 Nov 01, 2017	BUY	$24.5 - $31.1 $2.93 Million - $3.71 Million	119,433	119,433 $3.7 Million

Others Institutions Holding SRDX

# of Institutions

157

Shares Held

11.8M

Call Options Held

219K

Put Options Held

255K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $583M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Surmodics Inc Transaction History